Vertex Pharmaceuticals Incorporated
VRTX
$312.37
-$1.88-0.60%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/30/2023
-
Fool.com Headlines
3/30/2023
-
Fool.com Headlines
3/30/2023
-
Fool.com Headlines
3/30/2023
-
Fool.com Headlines
3/30/2023
-
Zolmax
3/30/2023
-
Ticker Report
3/30/2023
-
Ticker Report
3/30/2023
-
Zolmax
Charles F. Wagner, Jr. Sells 1,768 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock
3/30/2023
-
Ticker Report
3/30/2023
-
InvestorPlace
3/29/2023
-
Fool.com Headlines
3/29/2023
-
Ticker Report
3/29/2023
-
Ticker Report
3/28/2023
-
Benzinga
3/28/2023
-
Zacks Investment Research
3/28/2023
-
Ticker Report
3/28/2023
-
Zolmax
3/28/2023
-
MarketBeat - AP News
3/28/2023
-
Ticker Report
3/27/2023
-
Zacks Investment Research
3/27/2023
-
Ticker Report
3/27/2023
-
Business Wire
3/27/2023
-
Zacks Investment Research
3/26/2023
-
Ticker Report
3/26/2023
-
Zolmax
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, February 10, 2023
Period Date
Saturday, December 31, 2022
Next Filing
Week of May 1 and 5 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 341 6100
Address
50 Northern Avenue
Boston, MA 02210
Boston, MA 02210
Country
Year Founded
Business Description
Sector
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO and...
more
